Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis

Chemotherapeutic intervention remains the primary strategy in treating and controlling tuberculosis (TB). However, a complex interplay between therapeutic and patient-related factors leads to poor treatment adherence. This in turn continues to give rise to unacceptably high rates of disease relapse...

Descripción completa

Detalles Bibliográficos
Autores principales: Afkhami, Sam, Villela, Anne Drumond, D’Agostino, Michael R., Jeyanathan, Mangalakumari, Gillgrass, Amy, Xing, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509172/
https://www.ncbi.nlm.nih.gov/pubmed/33013927
http://dx.doi.org/10.3389/fimmu.2020.557809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509172/
https://www.ncbi.nlm.nih.gov/pubmed/33013927
http://dx.doi.org/10.3389/fimmu.2020.557809

Ejemplares similares